Domov › Nevroblastom › Georgia
Klinične študije za Nevroblastom v Georgia
9 študij za Nevroblastom išče udeležence na lokacijah v Georgia.
Mesta v Georgia
Uradno besedilo študije (angleško)
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Memorial Health University Medical Center, Savannah
Vključevanje udeležencevFaza 3
Do 30 let · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT06172296Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
- Augusta University Health, Augusta
Vključevanje udeležencevFaza 2
Do 22 let · Vsi spoli · Posodobljeno 4. sep. 2026 · NCT02559778Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
- Memorial Health University Medical Center, Savannah
Vključevanje udeležencevFaza 3
365 Days – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT03126916Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 25. avg. 2026 · NCT04851119Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
- Augusta University Health, Augusta
Vključevanje udeležencevFaza 2
12 Months – 21 Years · Vsi spoli · Posodobljeno 12. avg. 2026 · NCT05489887Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Healthcare of Atlanta/Emory University School of Medicine, Atlanta
Vključevanje udeležencevFaza 1/2
12 Months – 30 Years · Vsi spoli · Posodobljeno 19. maj 2026 · NCT04901702Neuroblastoma Biology Study
- AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus, Atlanta
Vključevanje udeležencevOpazovalna študija
31 Days – 99 Years · Vsi spoli · Posodobljeno 23. mar. 2026 · NCT01587300Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma
- Children's Healthcare of Atlanta, Atlanta
Vključevanje udeležencev
Do 17 let · Vsi spoli · Posodobljeno 10. feb. 2026 · NCT06831552Allogeneic Expanded Gamma Delta T Cells With GD2 Chemoimmunotherapy in Relapsed /Refractory Neuroblastoma or Refractory/ Relapsed Osteosarcoma
- Children's Healthcare of Atlanta, Atlanta
Vključevanje udeležencevFaza 1
12 Months · Vsi spoli · Posodobljeno 26. dec. 2025 · NCT05400603Vir: ClinicalTrials.gov, podatki pridobljeni 5. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.